Next Article in Journal
“How about We Give It a Go?”: A Case Study on Supporting Breastfeeding Families in an Australian Child Care Centre
Previous Article in Journal
High Levels of Stress Due to the SARS-CoV-2 Pandemic among Parents of Children with and without Chronic Conditions across the USA
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Immersive Virtual Reality as Analgesia during Dressing Changes of Hospitalized Children and Adolescents with Burns: A Systematic Review with Meta-Analysis

1
Department of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, 3000 Leuven, Belgium
2
Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium
3
Department of Pediatrics, University Hospitals UZ Leuven, 3000 Leuven, Belgium
4
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium
5
Department of Clinical Pharmacy, Erasmus MC, 3000 GA Rotterdam, The Netherlands
*
Author to whom correspondence should be addressed.
All three first authors contributed equally to the manuscript, and are first authors.
Children 2020, 7(11), 194; https://doi.org/10.3390/children7110194
Submission received: 1 October 2020 / Revised: 14 October 2020 / Accepted: 18 October 2020 / Published: 22 October 2020

Abstract

:
Children and adolescents with severe burns require medical and nursing interventions, associated with pain. As immersive virtual reality (VR) gained prominence as non-pharmacological adjuvant analgesia, we conducted a systematic review and meta-analysis on the efficacy of full immersive VR on pain experienced during dressing changes in hospitalized children and adolescents with severe burns. This exercise included quality and risk of bias assessment. The systematic review resulted in eight studies and 142 patients. Due to missing data, four studies were excluded from the meta-analysis. Fixed effects meta-analysis of the four included studies (n = 104) revealed a large effect size (ES) (Standardized Mean Difference = 0.94; 95% Confidence Interval = 0.62, 1.27; Z = 5.70; p < 0.00001) for adjuvant full immersive VR compared to standard care (SC). In conclusion, adjuvant full immersive VR significantly reduces pain experienced during dressing changes in children and adolescents with burns. We therefore recommend implementing full immersive VR as an adjuvant in this specific setting and population. However, this requires further research into the hygienic use of VR appliances in health institutions. Furthermore, due to the high cost of the hardware, a cost–benefit analysis is required. Finally, research should also verify the long term physical and psychological benefits of VR.

1. Introduction

Burn injuries are a major public health problem with a high mortality rate [1]. The incidence rate of burn injuries for children aged under sixteen is almost 25% [2]. Children under the age of five are commonly involved, likely due to their underdeveloped motoric and cognitive functions [2,3].
Severely burned patients require frequent painful interventions, such as dressing changes to prevent infection and improve wound healing [4]. The frequency of dressing changes depends on the amount of exudate and type of dressing material, and therefore varies between once a week, up to twice daily in hospitalized burn patients [5]. The process of dressing change is perceived by children to be the most distressing and painful moment during hospitalization [4,6,7].
Failure to sufficiently handle this pain results in physical and psychological effects [8]. Unfortunately, pain management during dressing change is often insufficient with the traditional methods, resulting in anxiety in children and their parents [9]. Other psychological effects include depression and (posttraumatic) stress disorder [8]. Regarding the negative somatic effects, studies documented that pain blunts wound healing [10,11]. Therefore, accurate pain management not only improves quality of life, but also reduces the aforementioned negative effects. Different pain management strategies are used, with (opioid) analgesics as the most commonly applied strategy [12]. However, reports show that the pain experienced by burn patients during wound care remains unacceptably high, even with the maximum allowed doses [13]. Additionally, the use of pharmacological analgesics in general causes side effects like nausea, vomiting, dizziness, respiratory depression, constipation, or tolerance. Physical dependence and addiction are also concerning [14].
Interestingly, distraction interventions as adjuvant therapies—together with opioids—hold the promise to decrease pain and anxiety in burn patients [8,15,16,17]. There are various types of distraction, with a range of passive (e.g., watching television or listening to music) or active (e.g., interactive toys, electronic games, or immersive technology) techniques [18]. Due to the rapid development of immersive technology in the last decade, there is a growing interest for this technology as distraction intervention. McDonnell (2019) [19] describes two technologies that are covered by the term “immersive technology”: augmented reality (AR) and virtual reality (VR). Poetker (2019) [20] describes AR: “AR technology adds layers of digital snippets on top of an existing environment, bridging the gap between the virtual and physical world.”. In other words, AR occurs in the real-world environment, where virtual objects are superimposed onto the real-world environment [21]. In contrast, VR is described as “a fully digital experience that can either simulate or differ completely from the real world.” [20]. Thus, the main difference between VR and AR is the environment where the activity takes place. Consequently, unlike VR, AR is not a fully immersive technology.
Previous studies compared immersive to non-immersive VR and reported that immersive VR is more effective in acute or chronic pain [22,23,24,25,26,27]. More specific, VR was more effective than video games in burn wound care [28]. Furthermore, it is also more effective than cognitive–behavioral techniques like watching a video or listening to music [29,30]. The participants’ stronger illusion of presence in VR games, through immersion and involvement by convergence of multisensory inputs, plays a crucial role in its effectiveness [13]. “The essence of immersive virtual reality analgesia is the patient’s illusion of going to a different place, the subjective experience of feeling present in the computer-generated world, as if the virtual reality world is a place they are visiting”, which indicates that VR works through an attentional mechanism of psychological pain distraction [31]. Mallari et al. (2019) [32] defined full immersive VR as “being engaged in a simulated world in the form of visual and auditory feedback with the ability to interact with and/or elicit a reaction from their virtual environment.” This further builds on the gate-control mechanism, which assumes that interpretation of pain intensity of an incoming signal depends on the patient’s focus, as the brain has a limited processing capacity [33,34]. Researchers argue therefore that when the patient’s attention is distracted by VR, less attention will be available for pain perception [23,28,31,35,36]. Therefore, we chose to only focus and investigate the effect of full immersive VR as most immersive technology.
Both hardware and software are required to use immersive VR. The hardware of traditional VR systems consists of a head-mounted device (HMD) with three-dimensional (3D) goggles, headphones, sensory input devices, and/or body tracking sensors [20,37,38]. The HMD creates an experience of movement through the virtual world by tracking the patients head movements [37]. This enables the user a multisensory experience. The software allows users to create different environments, commonly selected based on patient preferences. Furthermore, patients can adopt an interactive avatar to explore this virtual environment [38]. Different studies state that immersive VR has positive effects on pain in adults, children, and adolescents [9,28,39,40,41]. Several studies evaluated the effectiveness of VR during wound care in burn patients, and have demonstrated the effects of VR as adjuvant to pharmacotherapy [13,27,28,31,42].
This systematic review aims to provide an overview of the effect on pain of fully immersive VR in hospitalized children and adolescents with burn injuries during dressing changes. By conducting a subsequent meta-analysis, we aim to determine the effect size (ES) of immersive VR compared to standard care (SC). Such findings are fruitful to improve nursing care, pain management and to guide future research.

2. Materials and Methods

2.1. Eligibility Criteria

Articles had to document primary research and had to be published in peer reviewed journals in either English or Dutch, without limitation on publication date. Exclusion criteria: the application of non-immersive VR, semi-immersive VR, or other distraction interventions, any other kind of wound care besides burns and/or if results of children and adults were pooled and remained indistinguishable. Reviews, conference papers, and abstracts were also excluded. For inclusion in the meta-analysis, studies were eligible if the following data were available: a mean and/or median score —and a measure for dispersion—for pain during the procedure for both the immersive VR group (VRG) and the standard care group (SCG).
Participants were considered eligible if they were: burn patients aged 2–18 years, hospitalized, and undergoing wound care. Patients had to be able to score their own pain, with or without a visual tool. We chose to only include self-reported measures by children. For the subsequent meta-analysis, we only included validated pain scales that quantified the pain experienced. Burn patients were defined as patients with second and/or third-degree burns, without limitations based on the location of the burns.
As studies should evaluate the effect of full immersive VR on pain in children and/or adolescents with burns, at least one assessment with and one without the intervention was required. Restrictions on the intensity, duration, and/or frequency of the immersive VR intervention were not applied. Our focus was on outcomes assessed during dressing changes. When outcomes during dressing changes were not evaluated, we selected the moment of evaluation closest to the completion of the procedure.

2.2. Search Strategy

Following electronic databases were used to gather relevant scientific articles: PubMed, Embase and CINAHL. A list of search strategies and keywords for PubMed (Table S1), Embase (Table S2) and CINAHL (Table S3) are provided. The PubMed search was conducted on 26 February 2020. Embase and CINAHL on 27 February 2020. Forward and backward snowball-methods were used to gather additional relevant articles. Both snowball methods were performed between 28 February and 5 March 2020, and were based on the results of the primary search. Finally, on 22 March 2020 a rerun of all searches was performed.

2.3. Data Collection

2.3.1. Studies Selection

The primary search in PubMed, CINAHL and Embase resulted in 95 articles. One additional article was identified throughout the snowball-method. After excluding duplicates, 61 articles were retained. Article screening was conducted in two phases. During primary screening, these 61 articles were independently screened based on title and abstract. If there were any discrepancies, an independent researcher (A.K.) was asked to take the final decision. This resulted in the exclusion of 49 articles. During secondary screening, full-texts of the remaining twelve articles were read and assessed for eligibility. Articles were included if predetermined inclusion criteria were met. The full-text of each article was independently read and assessed by F.R., Y.L., and K.C. An independent researcher (A.K.) was asked to take the final decision in the event of discrepancies. This resulted in the inclusion of eight articles.
The rerun of the search strategy in PubMed, CINAHL and Embase yielded two new articles. All newly retrieved articles were evaluated and excluded. An extensive overview of the study selection process is shown in Table S4.

2.3.2. Data Extraction

For each article we tried extracting following study characteristics: author(s), year of publication, title, study design, number of participants, age, study population, moment of VR, duration of VR, VR equipment, VR environment, treatment conditions, comparison intervention, key findings, type and moment of outcome measure(s), and relevant statistical test results. Each author had to independently extract the data. These data were subsequently reviewed by a second author. The third author was available in the event of discrepancies. For the meta-analysis the various pain scale scores were converted to a scale of 100. We chose to convert the units of effect measure to calculate with a higher accuracy and to pool data for the meta-analysis. The main characteristics and results of studies retained in the systematic review were tabulated (Appendix A Table A1, Table A2, Table A3 and Table A4).

2.4. Data Analysis

2.4.1. Assessment of Study Quality

Quality of Evidence

The quality of each included article was independently evaluated by two researchers. This was done using either the Physiotherapy Evidence Database (PEDro) scale (Appendix A Table A5) or the Modified Downs and Black index (MD & B) (Appendix A Table A6). A PEDro score between 6 and 10 indicates high quality, a PEDro score of 4–5 is fair, while a PEDro score <3 reflects poor quality [43]. A MD & B score <14 reflects poor quality [44].

Assessment of Risk of Bias

The risk of bias was independently assessed by K.C. and Y.L. The third researcher (R.F.) was consulted if there were any discrepancies. Assessment was performed with either the Risk of Bias (RoB) 2 tool [45] or the Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) tool [46]. Using the online Risk of Bias Visualization (robvis) tool, we constructed different plots (Appendix A Figure A1, Figure A2, Figure A3 and Figure A4) to list the assessed risk of bias per article [47].

2.4.2. Synthesis of Results

Measures of Treatment Effect

The meta-analysis was performed using RevMan 5.3 [48]. The ES measure was calculated by comparing the difference in treatment. Where possible, Cohen’s d with a 95% confidence interval (CI) was calculated. We used the following guideline for interpreting the ES: 0.2 = small, 0.5 = medium and 0.8 = large effect [49]. Furthermore, heterogeneity was calculated using the I2 test, as the Chi2 test has a lower power for small sample size studies [50]. The following rule was used to assess heterogeneity: 25% = low, 50% = moderate, and 75% = high [51].

Dealing with Missing Data

If summary data were unavailable, we tried to calculate them with the available data or aimed to contact the corresponding author(s). If none of these methods worked, the article could not be included in the meta-analysis.

Data Synthesis

Data were included in this meta-analysis when the target population, intervention, and outcome of interest were in line with the inclusion criteria. For each study included, we calculated the standardized mean difference (SMD) and their 95% CI using a fixed effects model. Using RevMan, we visualized calculations with a forest plot. Chan et al. (2007) [13] did not mention the standard deviation (SD) of the reported pain intensity during dressing change. We could however calculate the SD using the reported standard error (SE).

3. Results

3.1. Description of Studies

We summarized the main characteristics and results of studies retained in the systematic review in Figure 1 and Appendix A Table A1, Table A2, Table A3 and Table A4. Studies were conducted between 2000 and 2019. In all studies, adjuvant VR was compared to SC, except for Hoffman et al. (2000) [28] who used standard care in combination with a video game as comparison intervention.

3.1.1. Excluded Studies

During secondary screening, the full-texts of the remaining twelve studies were read by at least two researchers. Among the twelve studies, four were excluded: two studies [53,54] did not have the target population and the other two articles [55,56] did not have the target intervention. Additionally, two articles [57,58] were found in the rerun, but were excluded.
For inclusion in the meta-analysis, studies required aforementioned summary data. Since some data were unavailable, we tried to contact the authors of the following articles: van Twillert et al. (2007) [59] and Jeffs et al. (2014) [60]. van Twillert et al. (2007) [59] replied that they were no longer able to share their original research data. Jeffs et al. (2014) [60] as well failed to grant access to the raw data. These two articles could therefore not be included in the meta-analysis. The studies of Hoffman et al. (2000) [28] (n = 2) and Scapin et al. (2017) [8] (n = 2) were excluded because of their study design.

3.1.2. Included Studies

Eight studies remained included, reporting on 142 eligible participants. The study of van Twillert et al. (2007) [59] included 19 participants between 8 and 65 years, so that we only extracted data of participants <18 years (n = 6). The other seven studies included participants aged between 5 and 17 years [8,9,13,28,31,60,61]. Of these eight studies, four studies [9,13,31,61] were included in the meta-analysis. Details about the studies are summarized in Appendix A Table A1, Table A2, Table A3 and Table A4.
Six studies used a randomized controlled trial (RCT) research design, of which four used a within-subject design and two a between-subject design. The two remaining studies were case series. In line with the selection criteria, all studies used immersive VR adjuvant to SC during wound care. However, different VR environments were used.
The visual analogue scale (VAS) was used in two articles [28,61] and the faces scale in three articles [8,9,13]. The visual analogue thermometer (VAT) was used in the article of van Twillert et al. (2007) [59]. VAT is an adaptation of the VAS which was developed to measure pain in patients with burns [62]. The article of Hoffman et al. (2019) [31] used the graphic rating scale (GRS) as a method of pain measurement. In the article of Jeffs et al. (2014) [60], a combination of adolescent pediatric pain tool (APPT) and word GRS (WGRS) was used. The WGRS is an adaptation of the GRS which was developed to measure pain in pediatric patients [63].

3.2. Study Quality Assessment

3.2.1. Quality of Evidence

All included studies had generally moderate to high quality. For the six RCTs, five studies [9,13,31,59,60] were rated a PEDro-score of 7/11 and the study of Kipping et al. (2012) [61] a PEDro-score of 8/11. These scores can be explained because of allocation or non-availability of all data due to patient dropout. The two other articles [8,28] rated with MD & B, received both a rating of 15/27 (Appendix A Table A5).

3.2.2. Risk of Bias

Randomized Control Trials

The summary of risk of bias assessments of all included studies are shown in the Appendix A Figure A1, Figure A2, Figure A3 and Figure A4. For bias related to randomization, one study was judged to have a "low" risk of bias due to adequate information [60,61]. Four studies [9,13,31,59] were judged to have "some concerns" of bias since a random allocation sequence was used, but no information was published on the allocation sequence concealment until enrolment and assignment. Blinding for this type of intervention (performance bias) is almost impossible due to the nature of the intervention. Although an independent assessor can be blinded. Thus, 2/8 studies [9,60] were single blinded. The study of Das et al. (2005) [9] analyzed data through a blinded assessor. In the study of Jeffs et al. (2014) [60] the key outcomes were collected through blinded study team members. The studies of van Twillert et al. (2007) [59] and Kipping et al. (2012) [61] indicated the difficulty of using double blinding but it was unclear if these and the remaining studies [8,13,28,31] used any blinding strategy.
A total of five studies [13,31,59,60,61] were judged to have a low risk of bias for incomplete outcome data due to the availability of the outcome of interest for all participants. The study of Das et al. (2005) [9] was rated as some concerns, because two participants were excluded related to side effects claimed to be caused by analgesics. Two studies [9,60] were judged low risk of bias for the outcome measurement as an appropriate method to measure the outcome of interest and unawareness of outcome assessors of the intervention were used. Three studies [13,59,61] were rated to have some concerns of bias because of their unclarity on the outcome assessors’ awareness of the intervention. Only one study [31] was judged to have a "high" risk of bias in outcome measurement as assessors were likely aware about the intervention. Finally, six studies were classified as [9,13,31,59,60,61] low risk of bias due to their preselected data analysis plan.

Non-Randomized Studies

ROBINS-I tool [46] was used to assess the quality in the two case series studies [8,28]. We rated these studies as low risk of bias for all eligibility criteria. Figure A3 shows the risk of bias across both case series studies.
The low risk of bias was due to no potential for confounding the intervention effect, participant selection was not based on characteristics observed after the start of intervention, a clear description of the intervention and there were no deviations reported from the intended intervention. The outcome of interest was provided for all participants and no systematic errors in intervention assessments were retrieved.

3.2.3. Effect of the Intervention

Summary of Results for Studies Excluded from the Meta-Analysis

The two included case series [8,28], which each had two participants, reported that VR had a respectively relevant and considerable effect on pain reduction in children during wound care. In the study of Scapin et al. (2017) [8], the first patient scored his pain during SC 10/10 and during VR intervention 4/10. The second patient rated his pain level during SC 6/10 and during the VR intervention 0/10. In the study of Hoffman et al. (2000) [28], the first patient’s pain rating showed considerable reduction of 80 mm for the first VR session and 30 mm for the second VR session, compared to the control condition. The second patient showed a reduction of 47 mm in worst pain during VR intervention compared to the control condition.
In the study of van Twillert et al. (2007) [59] (n = 6), an overall tendency of remarkable pain reduction was reported in the VRG during dressing change. This comparison was made between the day before VR was offered, the day of VR and the day after VR. On the days before and after VR was offered, SC was provided. Moreover, the mean pain experienced was 2.90 (VRG) vs. 5.85 (SCG). The mean difference between the VRG and the SCG was −2.95 (p = 0.688). Furthermore, within-patient differences between the groups were significant (F = 13.2; p < 0.01).
The study of Jeffs et al. (2014) [60] (n = 28) showed that the VRG experienced less procedural pain than the SCG, but the difference was not statistically significant (difference = 9.7 mm; 95% CI = −9.5, 28.9; p = 0.32). Additionally, the estimated ES of self-reported pain scores between the VRG and the SCG was 0.535. In this study, it is also reported that the estimated procedural pain score (adjusted for various factors as age, sex, state anxiety, and pre-procedural pain, opioid drugs, and duration of treatment) is 28.7 (VRG) and 38.4 (SCG) [60].
The four studies included in this meta-analysis (n = 104) [9,13,31,61] found that VR adjuvant to SC reduced pain during dressing changes. Two out of four found that the effect was statistically significant (Das et al., 2007 [9], p < 0.01 and Hoffman et al., 2019 [31], p < 0.001). Pooling all four studies [9,13,31,61] was acceptable due to the homogeneity of the intervention and the study population. Moreover, the heterogeneity was calculated as moderate (I2 = 52%), confirming our decision to pool these studies [50]. Since the level of heterogeneity is moderate, we opted to use a fixed effects model. ES for self-reported pain could be generated for 4/8 studies [9,13,31,61]. Using the fixed-effects model, a large ES was found for VR on self-reported pain during dressing changes within our pre-specified range of age (SMD = 0.94; 95% CI = 0.62, 1.27; Z = 5.70; p < 0.00001) (Figure 2). This indicates a substantial clinical benefit. For further assessment of a publication bias, a funnel plot was used. Although our funnel plot does not include many studies, you can see there is some kind of symmetry present, which indicates or at least suggests absence of publication bias (Appendix A Figure A5).

4. Discussion

The aim of this review with meta-analysis was to summarize the existing evidence, and investigate the efficacy of full immersive VR as analgesia for hospitalized children and adolescents during dressing changes for burns. We hereby identified eight studies (sample size ranged from 2 to 48; 142 patients included) to evaluate the effect of immersive VR on pain based on self-reported outcomes. The two included case series [8,28] also reported a substantial influence of VR on pain reported during dressing change in children and adolescents with burns. The meta-analysis consisted of 4/8 eligible studies [9,13,31,61]. According to Scheffler et al. (2018) [64], non-pharmacological interventions including VR have significant effects on pain relief during burn wound care in adults. Moreover, Birnie et al. (2018) [65], demonstrated the positive effect of VR distractions on reducing needle-related pain and distress in children. In line with these studies, this systematic review and meta-analysis states that VR has a reductive impact on the pain experienced among children and adolescents with burns during dressing changes compared to SC. However, there are still some remarks related to age range, timing of outcome assessment, analgesics administered, and blinding issues.
Previous research suggested that variables like age can impact treatment efficacy [64]. For example, Dahlquist et al. (2009) [65] implies that fully immersive VR is most effective in children between 10 and 14 years of age. In the included studies, the youngest hospitalized patient was five years old. This could be explained by the fact that children need to be able to express their pain verbally, which is difficult when they are younger. Therefore, children should be able to engage and interact with the VR stories to optimize the effect of VR [66].
The timing of outcome assessment may also influence VR efficacy. All included studies used VR during dressing changes. However, the exact moment of self-reported pain assessment varies between studies. Most of the studies [9,28,31,60] measured self-reported pain after wound care to avoid interrupting the intervention. Chan et al. (2007) [13], Kipping et al. (2012) [61] and Scapin et al. (2017) [8] evaluated self-reported pain before, during, and after dressing changes. In contrast, van Twillert et al. (2007) [59] only evaluated outcome measures during dressing changes. Furthermore, the timing of VR application within each patient’s hospitalization or healing process also varies among these studies. van Twillert et al. (2007) [59] looked at patients with an expected hospital stay for at least four days, where VR would be assessed within the first week of admission. Das et al. (2005) [9] compared VR against SC during the patient’s second or third dressing change. Chan et al. (2007) [13] looked at patients who were on their third to fifth day after their burn accident to compare VR with SC. Scapin et al. (2017) [8] and Hoffman et al. (2019) [31] did not mention these specific criteria. However, we could derive some information of the case series of Scapin et al. (2017) [8]. The first case got the intervention on day one, the second case on day eight after admission [8]. The study of Hoffman et al. (2000) [28] looked at patients’ first dressing change after skin graft surgery. Finally, Kipping et al. (2012) [61] and Jeffs et al. (2014) [60] used the intervention on patients during their first conscious dressing change. We could not yet retrieve data on the impact of repeated, intra-patient VR use.
The use of pharmacological analgesia in the included studies was poorly described. In the study of Chan et al. (2007) [13] paracetamol was used, while in the study of Scapin et al. (2017) [8] morphine was used. Unfortunately, this was the only information on analgesics provided. Therefore, the experience of pain among the included studies could be influenced by the use of different types or doses of analgesics.
Four out of six RCTs [9,13,31,59] adopted a within-subject design to eliminate differences in SCG and pain perception. However, this type of design and intervention, made it almost impossible to blind the participants for the VR intervention. Therefore, there will always be a risk of bias due to placebo effects. In addition to the patients, it is also nearly impossible to blind the assessors during the VR intervention, which increases the risk of performance bias.
This meta-analysis has some methodological limitations. Due to our specific research topic and strict criteria, we were only able to include eight studies in our review. Additionally, because most of these studies have relatively small sample sizes, it is difficult to generalize the outcome. Furthermore, we were unable to perform a subgroup analysis because of the small samples in the included studies. Although published guidelines for RCT-reporting are available [67], many authors still did not include all their summary statistics. The snowball-method was applied to 60 articles which were divided among the three reviewers. The absence of a second opinion during this process could have induced selection bias. Selection bias could also have arisen because we were not blinded for each other’s scores during the screening of articles.
The strengths of this review consist of a thorough and up to date literary search, which focused on a high quality of evidence. Six out of eight included studies were identified as RCTs and were evaluated with the PEDro-scale as high quality. Although case series are not considered as the highest quality of evidence, they were both evaluated as moderate to high quality using the MD & B-checklist. Furthermore, we used strict predetermined inclusion and exclusion criteria for eligibility in this review and meta-analysis.
With the result of our meta-analysis, we can state that VR does have a reductive impact on the pain experienced among children and adolescents with burns during dressing changes. Therefore, we suggest that VR should be used as adjuvant therapy in children with burns. However, a larger sample size can help to better understand the efficacy of VR as an adjuvant treatment for pain relief within this specific population. From a clinical research perspective, this also means that research should shift from single short term efficacy compared to placebo studies, to more repeated use or comparative approaches, cost-effectiveness, and safety studies. It is commonly suggested that VR requires expertise, time, and effort. However, it seems that VR systems can be applied without a lot of time and effort in clinical routine care [25]. This requires further research into the hygienic aspects of VR use in health institutions. As time efficiency is another key criterion of health care, research on this aspect is recommended. Furthermore, due to the hardware costs, these aspects should also be included in a cost-benefit analysis. Finally, research should also verify the long term physical and psychological effects of VR, including repeated use.

5. Conclusions

This review presents important information regarding the effectiveness of VR as an adjuvant therapy during wound care in children and adolescents. Adjuvant full immersive VR reduces pain during dressing changes in children and adolescents with burns, as shown in the results of our meta-analysis. Therefore, we recommend the use of VR in hospitalized children with burns. Furthermore, the present systematic review and meta-analysis could be used to guide future research and improve current practice among children and adolescents with burn injuries.

Supplementary Materials

The following are available online at https://www.mdpi.com/2227-9067/7/11/194/s1. Table S1: Search strategy PubMed, Table S2: Search strategy CINAHL, Table S3: Search strategy Embase, Table S4: Screening process.

Author Contributions

Conceptualization, F.R.; methodology, K.C. and Y.L.; formal analysis; K.C., Y.L., and F.R.; investigation, K.A., K.C., Y.L., and F.R.; resources, Y.L.; writing—original draft preparation, K.C., Y.L., and F.R.; writing—review, K.C., Y.L., and F.R.; supervision, K.A.; reading and editing, K.A., J.T., and S.B. All authors have read and agreed to the published version of the manuscript.

Funding

This review received no external funding.

Acknowledgments

First: we would like to thank our friends and family for their help and support throughout the process. Secondly, we would also like to thank the experts, Jaan Toelen and Susan Broekmans, for their advice and expertise. Finally, a special thanks to Karel Allegaert who guided us throughout the whole process of developing this article.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Table A1. Summary of findings for the included studies.
Table A1. Summary of findings for the included studies.
Author
(Year)
TitleStudy DesignPatients
n * (Age)
Study PopulationMoment of VRDuration of VR
Chan (2007) [13]Application of a virtual reality prototype for pain relief of pediatric burn in TaiwanRCT: within-subjects, cross-over design8 (Mean 6,54 (SD = 2.27))Hospitalized pediatric patients with burnsDuring burn dressing change15–35 min
Das
(2005) [9]
The efficacy of playing a virtual reality game in modulating pain for children with acute burn injuries: a randomized controlled trial [ISRCTN87413556]RCT: within-subjects design7 (5–16)Hospitalized children with a TBSA >3% and requiring dressing changesDuring burn dressing change10–45 min
Hoffman (2000) [28]Virtual reality as an adjunctive pain control during burn wound care in adolescent patientscase series2 (16 and 17)Hospitalized pediatric patients with burnsDuring burn dressing change3 min
Hoffman (2019) [31]Immersive Virtual Reality as an Adjunctive Non-opioid Analgesic for Predominantly Latin American Children With Large Severe Burn Wounds During Burn Wound Cleaning in the Intensive Care Unit: A Pilot StudyRCT: within-subjects, cross-over design48 (6–17)Hospitalized children with a TBSA >10%During burn dressing changeMean 12.89 min
Jeffs
(2014) [60]
Effect of virtual reality on adolescent pain during burn wound careRCT: between-subjects, parallel design28 (10–17)Hospitalized pediatric patients with burnsDuring burn dressing changeMean 31.6 (SD = 30.8) min
Kipping (2012) [61]Virtual reality for acute pain reduction in adolescents undergoing burn wound care: a prospective randomized controlled trialRCT: between-subjects, parallel design41 (11–17)Adolescents with a TBSA >1%During burn dressing application2–62 min
Scapin (2017) [8]Use of virtual reality for treating burned children: case reportscase series2 (8 and 9)Hospitalized pediatric patients with burnsDuring burn dressing change25–35 min
Van Twillert (2007) [59]Computer-generated virtual reality to control pain and anxiety in pediatric and adult burn patients during wound dressing changesRCT: within-subjects design6 (8–18)Hospitalized pediatric patients with burns without facial burns or other physical limitationsDuring burn dressing changeMean 19.2 min
* Participants included in final analysis.
Table A2. Summary of findings for the included studies (continued).
Table A2. Summary of findings for the included studies (continued).
Author
(Year)
VR EquipmentVR Environment
Chan
(2007) [13]
VR-system with I-glasses and a computer mouse as inputThe patient functioned as a patrol person for an ice-cream factory. The purpose was preventing the fox from harming the factory by shooting at it with ice-cream
Das
(2005) [9]
A laptop (Dell Inspiron 5100, Pentium 4 2.4 Ghz CPU with a Radeon Mobility 7500 Video Card) with a head-mount display (HMD) (IOGlasses Head Mount Display with a SVGA video resolution of 800 × 600 16 million colors), with a tracking system (Intersense IS300 6 degree of freedom Inertia Cube with a USB-Serial converter, required for Inertia Cube)The patient visualized being on a track, using a pointer to aim and shoot monsters
Hoffman
(2000) [28]
A Silicon Graphics Octane MXE with Octane Channel Option coupled with a wide field of view head mounted visual display, a stationary Polhemus low energy source detected by movable Polhemus 6df sensors. Information about the sensor’s position relative to the source was fed into the VR computer systemThe patient experienced SpiderWorld. Using tactile augmentation patients could ’physically’ touch the furry body of a virtual Guyana bird-eating tarantula with wiggling legs
Hoffman (2019) [31]MX90 VR goggles from Nvis, with 90 degrees field of view diagonal, per eye, and 1280 × 1024 pixels resolution per eye. Held by the ’Magula arm’, a robot-like articulated arm goggle holderSnowWorld is an iceworld where patients interact with snowmen, igloos, penguins, wooly mammoths, and flying fish by throwing snowballs. During VR, patients heard music and 3D sound effects e.g., ice breaking when a snowball hits a snowman, mammoths trumpeted angrily when pelted, etc.
Jeffs
(2014) [60]
Kaiser Optics SR80a VR helmet with SXGA resolution (1280–1024) 80-degree field-of-view mounted on a custom-built, articulated-arm tripod device and via a desktop VR analgesia workstation Falcon NW Fragbox, with interactivity using a Kensington orbit trackball and music through Bose Quiet Comfort 3 headphonesSnowWorld is an iceworld where patients interact with snowmen, igloos, penguins, wooly mammoths, and flying fish by throwing snowballs. During VR, patients heard music and 3D sound effects e.g., ice breaking when a snowball hits a snowman, mammoths trumpeted angrily when pelted, etc.
Kipping (2012) [61]Head mounted display (eMagin, Z800 3DVisor with head tracking, joystick hand control (LOGIK PC ATTACK 3), personal computer and off the-shelf software gamesChicken Little™ for the 11–13 years old, and an additional choice of Need for Speed™ for the 14–17 years old
Scapin (2017) [8]Three-dimensional vision goggles and stereo sound from a Samsung Gear VR Innovator Edition for Note 4®. The images were reproduced by a Samsung Note S4® mobile phoneRoller coaster ride and a marine environment
Van Twillert (2007) [59]Cybermind Hi-Res900 3D Head Mounted Display was used with an integrated audio system and controlled by a FasTrak control-box: the Polhemus FasTrak 6 DOF motion tracking systemSnowWorld is an iceworld where patients interact with snowmen, igloos, penguins, wooly mammoths, and flying fish by throwing snowballs. During VR, patients heard music and 3D sound effects e.g., ice breaking when a snowball hits a snowman, mammoths trumpeted angrily when pelted, etc.
Table A3. Summary of findings for the included studies (continued).
Table A3. Summary of findings for the included studies (continued).
Author
(Year)
Treatment ConditionsComparison InterventionKey Findings
Chan
(2007) [13]
VR distraction with a standard pharmacologic analgesic (Tylenol)A standard pharmacologic analgesic (Tylenol)In the VR-group less pain was experienced during dressing change, but this was not statistically significant compared to the non VR-group (df = 7, t = 1.58, p > 0.05)
Das
(2005) [9]
VR distraction with routine pharmacological analgesiaRoutine pharmacological analgesiaThe average pain scores for only pharmacological analgesia was 4.1 (SD = 2.9), while VR coupled with pharmacological analgesia, the average pain score was 1.3 (SD = 1.8). The mean pain score difference between administrations was 3.2 (SD 2.1), which was significant using paired t-tests (p < 0.01)
Hoffman
(2000) [28]
VR distraction with standard pharmacological analgesiaNintendo 64 with standard pharmacological analgesiaBoth patients showed drops in pain during VR treatment compared to the comparison intervention
Hoffman (2019) [31]VR distraction with the usual standard pharmacological analgesiaTraditional pharmacological analgesiaVR significantly reduced children’s pain ratings during dressing change. Worst pain during No VR = 8.52 (SD = 1.75) vs. during Yes VR = 5.10 (SD = 3.27), t(47) = 7.11, p < 0.001, SD = 3.33, CI = 2.45–4.38, Cohen’s d = 1.03
Jeffs
(2014) [60]
VR distraction with standard careStandard careParticipants in the VR group reported less procedural pain compared with the SC group (difference = 9.7 mm, 95% CI: −9.5 to 28.9, p = 32). Pair-wise effect sizes were estimated between treatment groups. The estimated effect size between VR and SC groups was 0.535
Kipping (2012) [61]VR distraction with standard medication protocols (Entonox)Standard medication protocols (Entonox) with the possibility of TV, stories, music, caregivers or no distractionThe self-reported pain experienced during dressing application was lower in the VRG than the SDG. However, the difference was not statistically significant
Scapin (2017) [8]VR distraction with standard pharmacological treatment (Morphine)Standard pharmacological treatment (Morphine)Case 1: during the standard care the child scored his pain the maximum FACE-scale value (10/10). During VR intervention he scored his pain 4/10. Case 2: during standard care the child rated his pain 6/10. During the VR treatment was the pain rated 0/10
Van Twillert (2007) [59]VR distraction with standard pharmacological analgesiaStandard pharmacological care and the possibility of alternative distractions (TV, stories, music, caregivers or no distraction)Mean pain experienced by patients younger than 18: VR: 2.90 vs. SC: 5.85. Mean difference between VR and SC was −2.95 (p: 0.688)
Table A4. Summary of findings for the included studies (continued).
Table A4. Summary of findings for the included studies (continued).
Author
(Year)
Type of Outcome MeasureMoment of Outcome MeasureQuality AssessmentRisk of BiasStatistical SignificanceEffect Size95% CI (Lower Bounds)95% CI (Upper Bounds)
Chan
(2007) [13]
Faces scale (0–100)Before, during and after dressing changePEDro-scale: 7/11RoB 2: some concernsp > 0.050.44−0.561.43
Das
(2005) [9]
Faces scale (0–10)After dressing changePEDro-scale: 7/11RoB 2: some concernsp < 0.011.09−0.062.24
Hoffman
(2000) [28]
Visual analogue scale (0–100)After dressing changeMD&B: 15/27ROBINS-I: low risk////
Hoffman (2019) [31]Graphic rating scales (0–10)After dressing changePEDro-scale: 7/11RoB 2: high riskp < 0.0011.290.851.74
Jeffs
(2014) [60]
Adolescent pediatric pain tool—Word graphic rating scale (0–100)After dressing changePEDro-scale: 7/11RoB 2: low riskp = 0.320.53−9.5028.90
Kipping (2012) [61]Visual analog scale (0–10)Before, during and after dressing changePEDro-scale: 8/11RoB 2: some concernsp = 0.400.41−0.211.03
Scapin (2017) [8]Faces scale (0–10)Before, during and after dressing changeMD&B: 15/27ROBINS-I: low risk////
Van Twillert (2007) [59]Graphic rating scales (0–10)During dressing changePEDro-scale: 7/11RoB 2: some concernsp = 0.68///
Table A5. Pedro-scale adapted from “The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study.” by de Morton N.A., 2009, Aust J Physiother 55(2), p. 131 [43].
Table A5. Pedro-scale adapted from “The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study.” by de Morton N.A., 2009, Aust J Physiother 55(2), p. 131 [43].
CriteriaEvaluation
1.Eligibility criteria were specified?Yes (1)/No (0)
2.Subjects were randomly allocated to groups (in a crossover study, subjects were randomly allocated an order in which treatments were received)?Yes (1)/No (0)
3.Allocation was concealed?Yes (1)/No (0)
4.The groups were similar at baseline regarding the most important prognostic indicators?Yes (1)/No (0)
5.There was blinding of all subjects?Yes (1)/No (0)
6.There was blinding of all therapists who administered the therapy?Yes (1)/No (0)
7.There was blinding of all assessors who measured at least one key outcome?Yes (1)/No (0)
8.Measures of at least one key outcome were obtained from more than 85% of the subjects initially allocated to groups?Yes (1)/No (0)
9.All subjects for whom outcome measures were available received the treatment or control condition as allocated or, where this was not the case, data for at least one key outcome was analysed by “intention to treat”?Yes (1)/No (0)
10.The results of between-group statistical comparisons are reported for at least one key outcome?Yes (1)/No (0)
11.The study provides both point measures and measures of variability for at least one key outcome?Yes (1)/No (0)
Table A6. MD & B-checklist adapted from “The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomized studies of health care interventions” [44].
Table A6. MD & B-checklist adapted from “The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomized studies of health care interventions” [44].
CriteriaEvaluation
1.Is the hypothesis/aim/objective of the study clearly described?Yes (1)/No (0)
2.Are the main outcomes to be measured clearly described in the Introduction or Methods section?Yes (1)/No (0)
3.Are the characteristics of the patients included in the study clearly described?Yes (1)/No (0)
4.Are the interventions of interest clearly described?Yes (1)/No (0)
5.Are the distributions of principal confounders in each group of subjects to be compared clearly described?Yes (2)/Partially (1)/No (0)
6.Are the main findings of the study clearly described?Yes (1)/No (0)
7.Does the study provide estimates of the random variability in the data for the main outcomes?Yes (1)/No (0)
8.Have all important adverse events that may be a consequence of the intervention been reported?Yes (1)/No (0)
9.Have the characteristics of patients lost to follow-up been described?Yes (1)/No (0)
10.Have actual probability values been reported (e.g., 0.035 rather than < 0.05) for the main outcomes except where the probability value is less than 0.001?Yes (1)/No (0)
11.Were the subjects asked to participate in the study representative of the entire population from which they were recruited?Yes (1)/No (0)/Unable to determine (0)
12.Were those subjects who were prepared to participate representative of the entire population from which they were recruited?Yes (1)/No (0)/Unable to determine (0)
13.Were the staff, places, and facilities where the patients were treated, representative of the treatment the majority of patients receive?Yes (1)/No (0)/Unable to determine (0)
14.Was an attempt made to blind study subjects to the intervention they have received?Yes (1)/No (0)/Unable to determine (0)
15.Was an attempt made to blind those measuring the main outcomes of the intervention?Yes (1)/No (0)/Unable to determine (0)
16.If any of the results of the study were based on “data dredging”, was this made clear?Yes (1)/No (0)/Unable to determine (0)
17.In trials and cohort studies, do the analyses adjust for different lengths of follow-up of patients, or in case-control studies, is the time period between the intervention and outcome the same for cases and controls?Yes (1)/No (0)/Unable to determine (0)
18.Were the statistical tests used to assess the main outcomes appropriate?Yes (1)/No (0)/Unable to determine (0)
19.Was compliance with the intervention/s reliable?Yes (1)/No (0)/Unable to determine (0)
20.Were the main outcome measures used accurate (valid and reliable)?Yes (1)/No (0)/Unable to determine (0)
21.Were the patients in different intervention groups (trials and cohort studies) or were the cases and controls (case-control studies) recruited from the same population?Yes (1)/No (0)/Unable to determine (0)
22.Were study subjects in different intervention groups (trials and cohort studies) or were the cases and controls (case-control studies) recruited over the same period of time?Yes (1)/No (0)/Unable to determine (0)
23.Were study subjects randomized to intervention groups?Yes (1)/No (0)/Unable to determine (0)
24.Was the randomized intervention assignment concealed from both patients and health care staff until recruitment was complete and irrevocable?Yes (1)/No (0)/Unable to determine (0)
25.Was there adequate adjustment for confounding in the analyses from which the main findings were drawn?Yes (1)/No (0)/Unable to determine (0)
26.Were losses of patients to follow-up taken into account?Yes (1)/No (0)/Unable to determine (0)
27.Did the study have sufficient power to detect a clinically important effect where the probability value for a difference being due to chance is less than 5%?<n1 (0)/n1 - n2 (1)/n3 - n4 (2)/n5 - n6 (3)/n7 - n8 (4)/>n8 (5)
Figure A1. Risk of bias weighted summary plot: review authors’ judgements about each risk of bias item presented as percentages across all included randomized controlled trial (RCT) studies.
Figure A1. Risk of bias weighted summary plot: review authors’ judgements about each risk of bias item presented as percentages across all included randomized controlled trial (RCT) studies.
Children 07 00194 g0a1
Figure A2. Risk of bias traffic light plot: review authors’ judgements about each risk of bias item presented as percentages across all included RCT studies.
Figure A2. Risk of bias traffic light plot: review authors’ judgements about each risk of bias item presented as percentages across all included RCT studies.
Children 07 00194 g0a2
Figure A3. Risk of bias weighted summary plot: review authors’ judgements about each risk of bias item presented as percentages across all included non-randomized studies.
Figure A3. Risk of bias weighted summary plot: review authors’ judgements about each risk of bias item presented as percentages across all included non-randomized studies.
Children 07 00194 g0a3
Figure A4. Risk of bias traffic light plot: review authors’ judgements about each risk of bias item presented as percentages across all included non-randomized studies.
Figure A4. Risk of bias traffic light plot: review authors’ judgements about each risk of bias item presented as percentages across all included non-randomized studies.
Children 07 00194 g0a4
Figure A5. Funnel plot: fixed effects meta-analysis for the effect of VR on self-reported pain during dressing. Changes compared to SC.
Figure A5. Funnel plot: fixed effects meta-analysis for the effect of VR on self-reported pain during dressing. Changes compared to SC.
Children 07 00194 g0a5

References

  1. Elrod, J.; Schiestl, C.M.; Mohr, C.; Landolt, M.A. Incidence, severity and pattern of burns in children and adolescents: An epidemiological study among immigrant and Swiss patients in Switzerland. Burns 2019, 45, 1231–1241. [Google Scholar] [CrossRef] [PubMed]
  2. Bayat, A.; Ramaiah, R.; Bhananker, S.M. Analgesia and sedation for children undergoing burn wound care. Expert Rev. Neurother. 2010, 10, 1747–1759. [Google Scholar] [CrossRef] [PubMed]
  3. Stichting Brandwonden Epidemologie. Available online: www.brandwonden.be/nl/brandwondenzorg/eerste-hulp/epidemologie (accessed on 5 April 2020).
  4. Louw, Q.; Grimmer-Somers, K.; Schrikk, A. Measuring children’s distress during burns dressing changes: Literature search for measures appropriate for indigenous children in South Africa. J. Pain Res. 2011, 4, 263. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Herndon, D.N. Total Burn Care, 4th ed.; Elsevier: Amsterdam, The Netherlands, 2012; ISBN 9781437727869. [Google Scholar]
  6. Godambe, S.A.; Elliot, V.; Matheny, D.; Pershad, J. Comparison of Propofol/Fentanyl Versus Ketamine/Midazolam for Brief Orthopedic Procedural Sedation in a Pediatric Emergency Department. Pediatrics 2003, 112, 116–123. [Google Scholar] [CrossRef]
  7. Mather, L.; Mackie, J. The incidence of postoperative pain in children. Pain 1983, 15, 271–282. [Google Scholar] [CrossRef]
  8. Scapin, S.Q.; Echevarría-Guanilo, M.E.; Fuculo, P.R.B.; Martins, J.C.; Barbosa, M.d.V.; Pereima, M.J.L. Use of virtual reality for treating burned children: Case reports. Rev. Bras. Enferm. 2017, 70, 1291–1295. [Google Scholar] [CrossRef] [Green Version]
  9. Das, D.A.; Grimmer, K.A.; Sparnon, A.L.; McRae, S.E.; Thomas, B.H. The efficacy of playing a virtual reality game in modulating pain for children with acute burn injuries: A randomized controlled trial [ISRCTN87413556]. BMC Pediatr. 2005, 5, 1. [Google Scholar] [CrossRef]
  10. Christian, L.M.; Graham, J.E.; Padgett, D.A.; Glaser, R.; Kiecolt-Glaser, J.K. Stress and Wound Healing. Neuroimmunomodulation 2006, 13, 337–346. [Google Scholar] [CrossRef] [Green Version]
  11. Widgerow, A.D.; Kalaria, S. Pain mediators and wound healing—Establishing the connection. Burns 2012, 38, 951–959. [Google Scholar] [CrossRef]
  12. Palos, G.R.; Mendoza, T.R.; Cantor, S.B.; Aday, L.A.; Cleeland, C.S. Perceptions of analgesic use and side effects: What the public values in pain management. J. Pain Symptom Manag. 2004, 28, 460–473. [Google Scholar] [CrossRef]
  13. Chan, E.A.; Chung, J.W.Y.; Wong, T.K.S.; Lien, A.S.Y.; Yang, J.Y. Application of a virtual reality prototype for pain relief of pediatric burn in Taiwan. J. Clin. Nurs. 2007, 16, 786–793. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Benyamin, R.; Trescot, A.M.; Datta, S.; Buenaventura, R.; Adlaka, R.; Sehgal, N.; Glaser, S.E.; Vallejo, R. Opioid complications and side effects. Pain Physician 2008, 11, S105–S120. [Google Scholar] [CrossRef] [PubMed]
  15. Byers, J.F.; Bridges, S.; Kijek, J.; LaBorde, P. Burn Patients’ Pain and Anxiety Experiences. J. Burn Care Res. 2001, 22, 144–149. [Google Scholar] [CrossRef] [PubMed]
  16. Chonière, M.; Melzack, R.; Rondeau, J.; Girard, N.; Paquin, M.-J. The Pain of Burns. J. Trauma 1989, 29, 1531–1539. [Google Scholar] [CrossRef]
  17. Perry, S.; Heidrich, G.; Ramos, E. Assessment of Pain by Burn Patients. J. Burn Care Res. 1981, 2, 322–326. [Google Scholar] [CrossRef]
  18. Koller, D.; Goldman, R.D. Distraction Techniques for Children Undergoing Procedures: A Critical Review of Pediatric Research. J. Pediatr. Nurs. 2012, 27, 652–681. [Google Scholar] [CrossRef]
  19. McDonnell, N. Immersive Technology and Medical Visualisation: A Users Guide. In Biomedical Visualisation. Advances in Experimental Medicine and Biology; Springer: Cham, Switzerland, 2019; Volume 1156, pp. 123–134. [Google Scholar]
  20. Poetker, B. What Is Virtual Reality? Available online: https://learn.g2.com/virtual-reality (accessed on 14 May 2020).
  21. Marr, B. The Important Difference between Virtual Reality, Augmented Reality and Mixed Reality. Available online: www.forbes.com/sites/bernardmarr/2019/07/19/the-important-difference-between-virtual-reality-augmented-reality-and-mixed-reality/ (accessed on 29 April 2020).
  22. Garrett, B.; Taverner, T.; Masinde, W.; Gromala, D.; Shaw, C.; Negraeff, M. A Rapid Evidence Assessment of Immersive Virtual Reality as an Adjunct Therapy in Acute Pain Management in Clinical Practice. Clin. J. Pain 2014, 30, 1089–1098. [Google Scholar] [CrossRef]
  23. Hoffman, H.G.; Seibel, E.J.; Richards, T.L.; Furness, T.A.; Patterson, D.R.; Sharar, S.R. Virtual Reality Helmet Display Quality Influences the Magnitude of Virtual Reality Analgesia. J. Pain 2006, 7, 843–850. [Google Scholar] [CrossRef]
  24. Macedonio, M.F.; Parsons, T.D.; Digiuseppe, R.A.; Weiderhold, B.A.; Rizzo, A.A. Immersiveness and Physiological Arousal within Panoramic Video-Based Virtual Reality. Cyberpsychol. Behav. 2007, 10, 508–515. [Google Scholar] [CrossRef] [Green Version]
  25. Malloy, K.M.; Milling, L.S. The effectiveness of virtual reality distraction for pain reduction: A systematic review. Clin. Psychol. Rev. 2010, 30, 1011–1018. [Google Scholar] [CrossRef]
  26. Shahrbanian, S.; Xiaoli, M.A.; Korner-Bitensky, N.; Simmonds, M.J. Scientific evidence for the effectiveness of virtual reality for pain reduction in adults with acute or chronic pain. In Proceedings of the Studies in Health Technology and Informatics; IOS Press: Amsterdam, The Netherlands, 2009; Volume 144, pp. 40–43. [Google Scholar]
  27. Wender, R.; Hoffman, H.G.; Hunner, H.H.; Seibel, E.J.; Patterson, D.R.; Sharar, S.R. Interactivity influences the magnitude of virtual reality analgesia. J. Cyber. Ther. Rehabil. 2009, 2, 27–33. [Google Scholar] [PubMed]
  28. Hoffman, H.G.; Doctor, J.N.; Patterson, D.R.; Carrougher, G.J.; Furness, T.A. Virtual reality as an adjunctive pain control during burn wound care in adolescent patients. Pain 2000, 85, 305–309. [Google Scholar] [CrossRef]
  29. Geisser, M.E.; Bingham, H.G.; Robinson, M.E. Pain and anxiety during burn dressing changes: Concordance between patients’ and nurses’ ratings and relation to medication administration and patient variables. J. Burn Care Rehabil. 1995, 16, 165–171. [Google Scholar] [CrossRef] [PubMed]
  30. Tan, S.-Y. Cognitive and cognitive-behavioral methods for pain control: A selective review. Pain 1982, 12, 201–228. [Google Scholar] [CrossRef]
  31. Hoffman, H.G.; Rodriguez, R.A.; Gonzalez, M.; Bernardy, M.; Peña, R.; Beck, W.; Patterson, D.R.; Meyer, W.J. Immersive Virtual Reality as an Adjunctive Non-opioid Analgesic for Pre-dominantly Latin American Children with Large Severe Burn Wounds During Burn Wound Cleaning in the Intensive Care Unit: A Pilot Study. Front. Hum. Neurosci. 2019, 13, 262. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Mallari, B.; Spaeth, E.K.; Goh, H.; Boyd, B.S. Virtual reality as an analgesic for acute and chronic pain in adults: A systematic review and meta-analysis. J. Pain Res. 2019, 12, 2053–2085. [Google Scholar] [CrossRef] [Green Version]
  33. Kahneman, D. Attention and Effort; Prentice-Hall: Englewood Cliffs, NJ, USA, 1973; ISBN 0130505188. [Google Scholar]
  34. Melzack, R.; Wall, P.D. Pain Mechanisms: A New Theory. Science 1965, 150, 971–978. [Google Scholar] [CrossRef]
  35. Hoffman, H. Virtual Reality: A New Tool for Interdisciplinary Psychology Research. Cyberpsychol. Behav. 1998, 1, 195–200. [Google Scholar] [CrossRef]
  36. Hoffman, H.G.; Chambers, G.T.; Meyer, W.J.; Arceneaux, L.L.; Russell, W.J.; Seibel, E.J.; Richards, T.L.; Sharar, S.R.; Patterson, D.R. Virtual Reality as an Adjunctive Non-pharmacologic Analgesic for Acute Burn Pain During Medical Procedures. Ann. Behav. Med. 2011, 41, 183–191. [Google Scholar] [CrossRef] [Green Version]
  37. Arane, K.; Behboudi, A.; Goldman, R.D. Virtual reality for pain and anxiety management in children. Can. Fam. Physician 2017, 63, 932–934. [Google Scholar]
  38. Pourmand, A.; Davis, S.; Marchak, A.; Whiteside, T.; Sikka, N. Virtual Reality as a Clinical Tool for Pain Management. Curr. Pain Headache Rep. 2018, 22, 53. [Google Scholar] [CrossRef] [PubMed]
  39. Ahmadi, M. Virtual Reality May Help Children Undergoing Chemotherapy. J. Natl. Cancer Inst. 2001, 93, 675–676. [Google Scholar] [CrossRef] [PubMed]
  40. Miller, K.; Rodger, S.; Bucolo, S.; Greer, R.; Kimble, R.M. Multi-modal distraction. Using technology to combat pain in young children with burn injuries. Burns 2010, 36, 647–658. [Google Scholar] [CrossRef] [PubMed]
  41. Morris, L.D.; Louw, Q.A.; Grimmer-Somers, K. The Effectiveness of Virtual Reality on Reducing Pain and Anxiety in Burn Injury Patients. Clin. J. Pain 2009, 25, 815–826. [Google Scholar] [CrossRef]
  42. Hoffman, H.G.; Patterson, D.R.; Magula, J.; Carrougher, G.J.; Zeltzer, K.; Dagadakis, S.; Sharar, S.R. Water-friendly virtual reality pain control during wound care. J. Clin. Psychol. 2004, 60, 189–195. [Google Scholar] [CrossRef]
  43. de Morton, N.A. The PEDro scale is a valid measure of the methodological quality of clinical trials: A demographic study. Aust. J. Physiother. 2009, 55, 129–133. [Google Scholar] [CrossRef] [Green Version]
  44. Downs, S.H.; Black, N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J. Epidemiol. Community Health 1998, 52, 377–384. [Google Scholar] [CrossRef] [Green Version]
  45. Sterne, J.A.C.; Savović, J.; Page, M.J.; Elbers, R.G.; Blencowe, N.S.; Boutron, I.; Cates, C.J.; Cheng, H.Y.; Corbett, M.S.; Eldridge, S.M.; et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 2019, 366, i4898. [Google Scholar] [CrossRef] [Green Version]
  46. Sterne, J.A.C.; Hernán, M.A.; Reeves, B.C.; Savović, J.; Berkman, N.D.; Viswanathan, M.; Henry, D.; Altman, D.G.; Ansari, M.T.; Boutron, I.; et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016, 355, i4919. [Google Scholar] [CrossRef] [Green Version]
  47. McGuinness, L.A. Robvis: An R Package and Web Application for Visualising Risk-of-Bias Assessments. Available online: https://github.com/mcguinlu/robvis (accessed on 9 April 2020).
  48. Review Manager (RevMan 5.3). Available online: https://training.cochrane.org/online-learning/core-software-cochrane-reviews/revman (accessed on 9 April 2020).
  49. Cohen, J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed.; Routledge: New York, NY, USA, 2013; ISBN 9780203771587. [Google Scholar]
  50. Higgins, J.; Thomas, J.; Chandler, J.; Cumpston, M.; Page, M.; Welch, V. Cochrane Handbook for Systematic Reviews of Interventions; Higgins, J.P.T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M.J., Welch, V.A., Eds.; Version 6; Wiley: Hoboken, NJ, USA, 2019; ISBN 9781119536628. [Google Scholar]
  51. Higgins, J.P.T. Measuring inconsistency in meta-analyses. BMJ 2003, 327, 557–560. [Google Scholar] [CrossRef] [Green Version]
  52. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009, 6, e1000097. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Faber, A.W.; Patterson, D.R.; Bremer, M. Repeated Use of Immersive Virtual Reality Therapy to Control Pain During Wound Dressing Changes in Pediatric and Adult Burn Patients. J. Burn Care Res. 2013, 34, 563–568. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Hua, Y.; Qiu, R.; Yao, W.; Zhang, Q.; Chen, X. The Effect of Virtual Reality Distraction on Pain Relief During Dressing Changes in Children with Chronic Wounds on Lower Limbs. Pain Manag. Nurs. 2015, 16, 685–691. [Google Scholar] [CrossRef] [PubMed]
  55. Hoffman, H.G.; Patterson, D.R.; Carrougher, G.J.; Sharar, S.R. Effectiveness of virtual reality-based pain control with multiple treatments. Clin. J. Pain 2001, 17, 229–235. [Google Scholar] [CrossRef]
  56. Mott, J.; Bucolo, S.; Cuttle, L.; Mill, J.; Hilder, M.; Miller, K.; Kimble, R.M. The efficacy of an augmented virtual reality system to alleviate pain in children undergoing burns dressing changes: A randomised controlled trial. Burns 2008, 34, 803–808. [Google Scholar] [CrossRef]
  57. Phelan, I.; Furness, P.J.; Fehily, O.; Thompson, A.R.; Babiker, N.T.; Lamb, M.A.; Lindley, S.A. A Mixed-Methods Investigation Into the Acceptability, Usability, and Perceived Effectiveness of Active and Passive Virtual Reality Scenarios in Managing Pain Under Experimental Conditions. J. Burn Care Res. 2019, 40, 85–90. [Google Scholar] [CrossRef]
  58. Schmitt, Y.S.; Hoffman, H.G.; Blough, D.K.; Patterson, D.R.; Jensen, M.P.; Soltani, M.; Carrougher, G.J.; Nakamura, D.; Sharar, S.R. A randomized, controlled trial of immersive virtual reality analgesia, during physical therapy for pediatric burns. Burns 2011, 37, 61–68. [Google Scholar] [CrossRef] [Green Version]
  59. van Twillert, B.; Bremer, M.; Faber, A.W. Computer-Generated Virtual Reality to Control Pain and Anxiety in Pediatric and Adult Burn Patients During Wound Dressing Changes. J. Burn Care Res. 2007, 28, 694–702. [Google Scholar] [CrossRef]
  60. Jeffs, D.; Dorman, D.; Brown, S.; Files, A.; Graves, T.; Kirk, E.; Meredith-Neve, S.; Sanders, J.; White, B.; Swearingen, C.J. Effect of Virtual Reality on Adolescent Pain During Burn Wound Care. J. Burn Care Res. 2014, 35, 395–408. [Google Scholar] [CrossRef] [Green Version]
  61. Kipping, B.; Rodger, S.; Miller, K.; Kimble, R.M. Virtual reality for acute pain reduction in adolescents undergoing burn wound care: A prospective randomized controlled trial. Burns 2012, 38, 650–657. [Google Scholar] [CrossRef]
  62. Choinière, M.; Auger, F.A.; Latarjet, J. Visual analogue thermometer: A valid and useful instrument for measuring pain in burned patients. Burns 1994, 20, 229–235. [Google Scholar] [CrossRef]
  63. Tesler, M.D.; Savedra, M.C.; Holzemer, W.L.; Wilkie, D.J.; Ward, J.A.; Paul, S.M. The word-graphic rating scale as a measure of children’s and adolescents’ pain intensity. Res. Nurs. Health 1991, 14, 361–371. [Google Scholar] [CrossRef]
  64. Scheffler, M.; Koranyi, S.; Meissner, W.; Strauß, B.; Rosendahl, J. Efficacy of non-pharmacological interventions for procedural pain relief in adults undergoing burn wound care: A systematic review and meta-analysis of randomized controlled trials. Burns 2018, 44, 1709–1720. [Google Scholar] [CrossRef] [PubMed]
  65. Birnie, K.A.; Noel, M.; Chambers, C.T.; Uman, L.S.; Parker, J.A. Psychological interventions for needle-related procedural pain and distress in children and adolescents. Cochrane Database Syst. Rev. 2018. [Google Scholar] [CrossRef] [PubMed]
  66. Dahlquist, L.M.; Weiss, K.E.; Law, E.F.; Sil, S.; Herbert, L.J.; Horn, S.B.; Wohlheiter, K.; Ackerman, C.S. Effects of Videogame Distraction and a Virtual Reality Type Head-Mounted Display Helmet on Cold Pressor Pain in Young Elementary School-Aged Children. J. Pediatr. Psychol. 2010, 35, 617–625. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Witmer, B.G.; Singer, M.J. Measuring Presence in Virtual Environments: A Presence Questionnaire. Presence 1998, 7, 225–240. [Google Scholar] [CrossRef]
Figure 1. Flow diagram after rerun adapted from “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.” by Moher D., Liberati A., Tetzlaff J. and Altman D.G., 2009, PLoS Med 6(7), p. 3 [52].
Figure 1. Flow diagram after rerun adapted from “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.” by Moher D., Liberati A., Tetzlaff J. and Altman D.G., 2009, PLoS Med 6(7), p. 3 [52].
Children 07 00194 g001
Figure 2. Forest plot: Fixed effects meta-analysis for the effect of virtual reality (VR) on self-reported pain during dressing changes compared to standard care (SC) [SD = standard deviation; IV = weighted mean difference; I2 = I-square heterogeneity statistic; CI = confidence interval; df = degrees of freedom; Z = Z statistic].
Figure 2. Forest plot: Fixed effects meta-analysis for the effect of virtual reality (VR) on self-reported pain during dressing changes compared to standard care (SC) [SD = standard deviation; IV = weighted mean difference; I2 = I-square heterogeneity statistic; CI = confidence interval; df = degrees of freedom; Z = Z statistic].
Children 07 00194 g002
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Lauwens, Y.; Rafaatpoor, F.; Corbeel, K.; Broekmans, S.; Toelen, J.; Allegaert, K. Immersive Virtual Reality as Analgesia during Dressing Changes of Hospitalized Children and Adolescents with Burns: A Systematic Review with Meta-Analysis. Children 2020, 7, 194. https://doi.org/10.3390/children7110194

AMA Style

Lauwens Y, Rafaatpoor F, Corbeel K, Broekmans S, Toelen J, Allegaert K. Immersive Virtual Reality as Analgesia during Dressing Changes of Hospitalized Children and Adolescents with Burns: A Systematic Review with Meta-Analysis. Children. 2020; 7(11):194. https://doi.org/10.3390/children7110194

Chicago/Turabian Style

Lauwens, Yannick, Fatemeh Rafaatpoor, Kobe Corbeel, Susan Broekmans, Jaan Toelen, and Karel Allegaert. 2020. "Immersive Virtual Reality as Analgesia during Dressing Changes of Hospitalized Children and Adolescents with Burns: A Systematic Review with Meta-Analysis" Children 7, no. 11: 194. https://doi.org/10.3390/children7110194

APA Style

Lauwens, Y., Rafaatpoor, F., Corbeel, K., Broekmans, S., Toelen, J., & Allegaert, K. (2020). Immersive Virtual Reality as Analgesia during Dressing Changes of Hospitalized Children and Adolescents with Burns: A Systematic Review with Meta-Analysis. Children, 7(11), 194. https://doi.org/10.3390/children7110194

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop